Objectives: (1) To measure the proportion of participants who used hypoglycaemic agents provided by CDAP only, for at least 6 months, and attained an HbA1c of Design And Methods: The attainment of a glycosylated haemoglobin (HbA1c) concentration of View Article and Find Full Text PDF